Skip to main content
. 2023 Jun 29;29(6):307–314. doi: 10.5761/atcs.oa.23-00041

Table 1. Preoperative characteristics.

Preoperative BTV group (n = 46) MTV group (n = 55) P
Age (years) 63.4 ± 8.9 52.4 ± 7.6 <0.01**
Sex (female) 33 (71.7) 37 (67.3) 0.628
BMI (kg/m2) 23.1 ± 6.2 21.7 ± 3.4 0.140
Diabetes mellitus (%) 5 (10.9) 3 (5.5) 0.526
Hypertension (%) 5 (10.9) 1 (1.8) 0.135
Smoking (%) 3 (6.5) 3 (5.5) 1.000
COPD (%) 1 (2.2) 4 (7.3) 0.474
Chronic kidney disease (%) 0 (0) 1 (1.8) 1.000
History of stroke (%) 1 (2.2) 2 (3.6) 1.000
NYHA class ≥3 (%) 34 (73.9) 35 (63.6) 0.269
LVEF (%) 61.4 ± 8.3 62.5 ± 7.8 0.496
Atrial fibrillation (%) 36 (78.3) 42 (76.4) 1.000
Hemoglobin (g/L) 116.0 ± 20.9 115.7 ± 23.2 0.944
Albumin (g/L) 40.9 ± 3.6 39.3 ± 3.6 0.026
Creatinine (μmoI/L) 70.0 ± 23.9 70.6 ± 17.6 0.885
Total bilirubin (μmoI/L) 23.4 ± 14.2 24.1 ± 12.1 0.804
Hepatomegaly (%) 20 (43.5) 34 (61.8) 0.066
TR (mL) 55 (30.8, 70.7) 56 (35, 84) 0.449
Right atrial volume (mL) 169.0 (118.8, 244.3) 207.0 (146.5, 321.5) 0.035 *
Aetiology of TR (%) 0.316
 Rheumatic 31 (67.4) 42 (76.4)
 Non rheumatic 15 (32.6) 13 (23.6)

*P <0.05, **P <0.01. BTV: bioprosthetic tricuspid valve; MTV: mechanical tricuspid valve; BMI: body mass index; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; TR: tricuspid regurgitation